Brian Mangal

958 total citations
19 papers, 672 citations indexed

About

Brian Mangal is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Brian Mangal has authored 19 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Brian Mangal's work include Atrial Fibrillation Management and Outcomes (6 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). Brian Mangal is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). Brian Mangal collaborates with scholars based in United States, Canada and Spain. Brian Mangal's co-authors include Joanne Brown, Gregory N. Beatch, Christian Torp‐Pedersen, Joshua M. Hare, Michael M. Givertz, Charles J. Fisher, Peter P. Liu, Ronald S. Freudenberger, Douglas L. Mann and Wilson S. Colucci and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Brian Mangal

16 papers receiving 655 citations

Peers

Brian Mangal

CCM

NEPHR

SURGE

PFM

Francisco Leyva‐Leon United Kingdom

Naoyuki Otani Japan

Shirley Yumi Hayashi Sweden

Angelica Parodi Italy

Michiko Togane Japan

Pin‐Ming Liu China

Xianchao Jing China

Chun Gyoo Ihm South Korea

Shinichi Antoku Japan

Ana Pérez de José Spain

Francisco Leyva‐Leon United Kingdom

Brian Mangal

137 ×0.3

CCM

332 ×1.5

NEPHR

117 ×1.0

120 ×1.1

SURGE

157 ×1.8

PFM

Citations per year, relative to Brian Mangal Brian Mangal (= 1×) peers Francisco Leyva‐Leon

Countries citing papers authored by Brian Mangal

Since Specialization

Citations

This map shows the geographic impact of Brian Mangal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Mangal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Mangal more than expected).

Fields of papers citing papers by Brian Mangal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Mangal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Mangal. The network helps show where Brian Mangal may publish in the future.

Co-authorship network of co-authors of Brian Mangal

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Mangal. A scholar is included among the top collaborators of Brian Mangal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Mangal. Brian Mangal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Desai, Milind Y., Sherif F. Nagueh, John R. Giudicessi, et al.. (2025). First-in-human study of TN-201, an AAV9 gene replacement therapy in MYBPC3 -associated hypertrophic cardiomyopathy: initial safety, pharmacodynamic, and imaging results from MyPEAK-1. Cardiovascular Research. 121(17). 2628–2631.

Maiti, Abhishek, Naval Daver, W. Thomas Johnson, et al.. (2024). ELA026, a Monoclonal Antibody Targeting Signal Regulatory Protein-α/β1/γ, Rapidly Controls Inflammation and Improves 2-Month Survival in Treatment-Naïve Malignancy-Associated Hemophagocytic Lymphohistiocytosis. Blood. 144(Supplement 1). 805–805. 1 indexed citations

Masana, L., Claus Peter Schmitt, Christina Taylan, et al.. (2024). Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study. The Lancet Diabetes & Endocrinology. 12(12). 880–889. 10 indexed citations

Masana, L., Alberto Zambon, Claus Peter Schmitt, et al.. (2023). Lomitapide for the treatment of paediatric homozygous familial hypercholesterolaemia patients - Results from the efficacy phase of the APH-19 study. SHILAP Revista de lepidopterología. 54. S9–S9. 1 indexed citations

Masana, L., Alberto Zambon, Claus Peter Schmitt, et al.. (2023). Lomitapide for the treatment of paediatric homozygous familial hypercholesterolaemia patients - Results from the efficacy phase of the APH-19 study. Atherosclerosis. 379. S23–S24. 3 indexed citations

Beatch, Gregory N. & Brian Mangal. (2016). Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial. BMC Cardiovascular Disorders. 16(1). 113–113. 19 indexed citations

Mishra, Vipin Kumar, et al.. (2016). STUDY OF PREVALENCE AND RISK FACTORS OF PERIPHERAL DIABETIC NEUROPATHY IN A TERTIARY HOSPITAL. Journal of Evolution of Medical and Dental Sciences. 5(13). 557–559. 1 indexed citations

Fleseriu, Maria, Шломо Мелмед, Brian Mangal, Christian J. Strasburger, & Nienke R. Biermasz. (2016). Longitudinal assessment of response to treatment with oral octreotide capsules in patients with acromegaly: post-hoc analysis of a phase 3 trial. Endocrine Abstracts. 4 indexed citations

Chen, Wilbur H., Lisa A. Jackson, Kathryn M. Edwards, et al.. (2015). Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant. Clinical and Vaccine Immunology. 23(1). 73–77. 11 indexed citations

10.

Chen, Wilbur H., Lisa A. Jackson, Kathryn M. Edwards, et al.. (2014). Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant. Open Forum Infectious Diseases. 1(3). ofu091–ofu091. 20 indexed citations

11.

Camm, A. John, Alessandro Capucci, Stefan H. Hohnloser, et al.. (2011). A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation. Journal of the American College of Cardiology. 57(3). 313–321. 183 indexed citations

12.

Torp‐Pedersen, Christian, et al.. (2011). A Randomized, Placebo-Controlled Study of Vernakalant (Oral) for the Prevention of Atrial Fibrillation Recurrence After Cardioversion. Circulation Arrhythmia and Electrophysiology. 4(5). 637–643. 30 indexed citations

13.

Rowe, Brian H., et al.. (2008). 22: The Conversion of Recent-Onset Atrial Fibrillation to Sinus Rhythm With Vernakalant Hydrochloride Injection: The Influence of Patients' Medical History and Baseline Characteristics. Annals of Emergency Medicine. 52(4). S48–S48. 1 indexed citations

14.

Hare, Joshua M., Brian Mangal, Joanne Brown, et al.. (2008). Impact of Oxypurinol in Patients With Symptomatic Heart Failure. Journal of the American College of Cardiology. 51(24). 2301–2309. 283 indexed citations

15.

Stiell, Ian G., et al.. (2007). 21: Efficacy and Safety of Vernakalant Hydrochloride Injection (RSD1235) for the Conversion of Acute Atrial Fibrillation in Patients Presenting to the Emergency Department Within 48 Hours of Onset. Annals of Emergency Medicine. 50(3). S7–S8.

16.

Roy, Denis, Craig M. Pratt, A. John Camm, et al.. (2006). Abstract 3697: RSD1235 Effectively Converts Atrial Fibrillation to Sinus Rhythm Independent of Background Use of Oral Rate- or Rhythm-Control Medications. Circulation. 114. 2 indexed citations

17.

Cingolani, Horacio E., et al.. (2006). The Effect of Xanthine Oxidase Inhibition Upon Ejection Fraction in Heart Failure Patients: La Plata Study. Journal of Cardiac Failure. 12(7). 491–498. 97 indexed citations

18.

Hare, Joshua M., Brian Mangal, Joanne Brown, et al.. (2006). Efficacy and Safety Study of Oxypurinol Added to Standard Therapy in Patients with New York Heart Association Class III-IV Congestive Heart Failure (The OPT-CHF Trial). Journal of Cardiac Failure. 12(9). 764–764. 1 indexed citations

19.

Stiell, Ian G., Denis Roy, Craig M. Pratt, et al.. (2006). 148. Annals of Emergency Medicine. 48(4). 46–47. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact